Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro

Acta Pharmacologica Sinica

Volumn 24, Issue 4, 2003, Pages 321-326

  Cao, Li Zhen ^a   Lin, Zhi Bin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cytotoxic T lymphocytes; Dendritic cells; Ganoderma lucidum; Polysaccharides; Serine endopeptidases

Indexed keywords

GAMMA INTERFERON; GANODERMA LUCIDUM EXTRACT; GRANZYME B; POLYSACCHARIDE; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL ADHESION; CELL CULTURE; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GANODERMA LUCIDUM; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN LYMPHOCYTE; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; DENDRITIC CELLS; FEMALE; GRANZYMES; INTERFERON TYPE II; MALE; MICE; MICE, INBRED C57BL; PLANTS, MEDICINAL; POLYSACCHARIDES; REISHI; RNA, MESSENGER; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037385404     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lin ZB. Pharmacological effects of Ganoderma lucidum. In: Lin ZB, editor. Modern research of Ganoderma lucidum. 2nd ed. Beijing: Beijing Medical University Press; 2001. p 219-83.
2. Lin ZB. Clinical applications of Ganoderma lucidum. In: Lin ZB, editor. Modern research of Ganoderma lucidum. 2nd ed. Beijing: Beijing Medical University Press; 2001. p 302-4.
3. Lin ZB. Pharmacological effects and clinical applications of Ganoderma lucidum. In: Zhou JH, Liu GZ, editors. Recent advances in Chinese herbal drugs - actions and uses. Beijing: Scientific Publishing House; 1991. p 133-40.
4. Lei LS, Lin ZB. Antagonistic effect of Ganoderma lucidum polysaccharides on the immunosuppressive response induced by cicloporin A, hydrocortisone and antitumor agents. Chin J Pharmacol and Toxicol 1993; 7: 183-5.
5. Lee SS, Wei YH, Chen CF, Wang SY, Chen KY. Antitumor effects of Ganoderma lucidum. J Chin Med 1995; 6: 1-12.
6. Lieu CW, Lee SS, Wang SY. The effect of ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res 1992; 12: 1211-6.
7. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS, et al. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 1997; 70: 699-705.
8. Zhang QH, Lin ZB. The antitumor activity of Ganoderma lucidum (Curt Fr) P Karst (Ling Zhi) (Aphyllophoromycetideae) polysaccharides is related to tumor necrosis factor-α and interferon-y. Int J Med Mushroom 1999; 1: 207-15.
9. Hu YH, Lin ZB. Effects of polysaccharides isolated from mycelia of Ganoderma lucidum on HL-60 cell apoptosis. Acta Pharm Sin 1999; 34: 268-71
10. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, L YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811.
11. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-52.
12. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001; 106: 263-6.
13. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001; 106: 259-62.
14. Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by ganoderma lucidum polysaccharides. Immunol Letters 2002; 83: 163-9.
15. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nat Med 1995; 1: 1297-302.
16. Matthias G, Sabine J, Georg V, Stephan G. Dendritic cells and tumor immunity. Semin Immunol 2001; 13: 291-302.
17. Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein RD. Tumor antigen presentation by murine epidermal cells. J Immunol 1991; 146: 3656-61.
18. Zhang PX, Chen WF. The method of the function study of immune cells. In: Ba DN, editor. Modern immune technique and application. Beijing: Beijing Medical University & Peking Union Medical College United Press; 1998. p 203-18.
19. Han CW, Imamura M, Hashino S, Zhu X, Tanaka J, Imai K, et al. Differential effects of the immunosuppressants cyclosporin A, FK506 and KM2210 on cytokine gene expression. Bone Marrow Transplantation 1995; 15: 733-9.
20. O'Connell PJ, Pacheco-Silva A, Nickerson PW, Muggia RA, Bastos M, Kelley VR, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093-104.
21. Fong L, Engleman EG. Dendritic cells in cancer immunotherapy. Annu Rev Immunol 2000; 18: 767-811.
22. Enk AH, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 1997; 73: 309-16.
23. Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med 1999; 5: 677-85.
24. Abdel-Wahab Z, DeMatos P, Hester D, Dong XD, Seigler HF. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide (280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity. Cell Immunol 1998; 186: 63-74.
25. Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol 1996; 170: 111-9.
26. Kägi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996; 14: 207-32.
27. Podack ER. Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr Opin Immunol 1995; 7: 11-6.
28. Kam CM, Hudig D, Powers JC. Granzymes (lymphocytes serine protease): characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta 2000; 1477: 307-23.
29. Trapani JA, Sutton VR, Smyth MJ. CTL granules: evolution of vesicles essential for combating virus infections. Immunol Today (Lib Ed) 1999; 20: 351-6.